Japan Hemostats Market Size, Share & Trends Analysis Report By Product (Thrombin-based Hemostats, Combination Hemostats), By Application (Orthopedic Surgery), By Formulation (Matrix & Gel Hemostats), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Research Methodology
                    1.3. Information Procurement
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Japan Hemostats Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing prevalence of chronic conditions
                            3.2.1.2. Rising geriatric population
                            3.2.1.3. Increasing number of surgeries
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Product recall & failure
                    3.3. Japan Hemostats Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological landscape
Chapter 4. Japan Hemostats Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Japan Hemostats Market: Product Movement Analysis & Market Share, 2023 & 2030
                    4.3. Japan Hemostats Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Thrombin-based Hemostats
                        4.4.1. Thrombin-based Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Oxidized Regenerated Cellulose-Based Hemostats
                        4.5.1. Oxidized Regenerated Cellulose-Based Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Combination Hemostats
                        4.6.1. Combination Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Others
                        4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Japan Hemostats Market: Formulation Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Japan Hemostats Market: Formulation Movement Analysis & Market Share, 2023 & 2030
                    5.3. Japan Hemostats Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
                    5.4. Matrix and Gel Hemostats
                        5.4.1. Matrix and Gel Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Sponge Hemostats
                        5.5.1. Sponge Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Powder Hemostats
                        5.6.1. Powder Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Others
                        5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Japan Hemostats Market: End-use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Japan Hemostats Market: End-use Movement Analysis & Market Share, 2023 & 2030
                    6.3. Japan Hemostats Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
                    6.4. Hospitals & Clinics
                        6.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Ambulatory Surgical Centers
                        6.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Casualty Care Centers
                        6.6.1. Casualty Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Others
                        6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Japan Hemostats Market: Application Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Japan Hemostats Market: Application Movement Analysis & Market Share, 2023 & 2030
                    7.3. Japan Hemostats Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    7.4. Orthopedic Surgery
                        7.4.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. General Surgery
                        7.5.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. Neurological Surgery
                        7.6.1. Neurological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.7. Cardiovascular Surgery
                        7.7.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.8. Others
                        7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Key Company Profiles
                        8.2.1. Johnson & Johnson Services, Inc.
                            8.2.1.1. Company overview
                            8.2.1.2. Financial performance
                            8.2.1.3. Product benchmarking
                            8.2.1.4. Strategic initiatives
                        8.2.2. CryoLife, Inc
                            8.2.2.1. Company overview
                            8.2.2.2. Financial performance
                            8.2.2.3. Product benchmarking
                            8.2.2.4. Strategic initiatives
                        8.2.3. Integra LifeSciences Corporation
                            8.2.3.1. Company overview
                            8.2.3.2. Financial performance
                            8.2.3.3. Product benchmarking
                            8.2.3.4. Strategic initiatives
                        8.2.4. Cohera Medical, Inc.
                            8.2.4.1. Company overview
                            8.2.4.2. Financial performance
                            8.2.4.3. Product benchmarking
                            8.2.4.4. Strategic initiatives
                        8.2.5. Pfizer
                            8.2.5.1. Company overview
                            8.2.5.2. Financial performance
                            8.2.5.3. Product benchmarking
                            8.2.5.4. Strategic initiatives
                        8.2.6. Cohesion Technologies
                            8.2.6.1. Company overview
                            8.2.6.2. Financial performance
                            8.2.6.3. Product benchmarking
                            8.2.6.4. Strategic initiatives
                        8.2.7. B. Braun Melsungen AG
                            8.2.7.1. Company overview
                            8.2.7.2. Financial performance
                            8.2.7.3. Product benchmarking
                            8.2.7.4. Strategic initiatives
                        8.2.8. Baxter
                            8.2.8.1. Company overview
                            8.2.8.2. Financial performance
                            8.2.8.3. Product benchmarking
                            8.2.8.4. Strategic initiatives
                        8.2.9. Medtronic
                            8.2.9.1. Company overview
                            8.2.9.2. Financial performance
                            8.2.9.3. Product benchmarking
                            8.2.9.4. Strategic initiatives
                        8.2.10. BD
                            8.2.10.1. Company overview
                            8.2.10.2. Financial performance
                            8.2.10.3. Product benchmarking
                            8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Japan hemostats market, by product, 2018 - 2030 (USD Million)
Table 4 Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 5 Japan hemostats market, by application, 2018 - 2030 (USD Million)
Table 6 Japan hemostats market, by formulation, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Surgical sealing and adhesives market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Japan hemostats market, product outlook key takeaways (USD Million)
Fig. 12 Japan hemostats market: product movement analysis (USD Million), 2023 & 2030
Fig. 13 Thrombin-based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Oxidized regenerated cellulose-based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Combination hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Japan hemostats market, end-use outlook key takeaways (USD Million)
Fig. 18 Japan hemostats market: end-use movement analysis (USD Million), 2023 & 2030
Fig. 19 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Casualty care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Japan hemostats market, application outlook key takeaways (USD Million)
Fig. 24 Japan hemostats market: application movement analysis (USD Million), 2023 & 2030
Fig. 25 Orthopedic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Neurological surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Japan hemostats market, formulation outlook key takeaways (USD Million)
Fig. 31 Japan hemostats market: formulation movement analysis (USD Million), 2023 & 2030
Fig. 32 Matrix and gel hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Sponge hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Powder hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)